Recent from talks
2CBFly-NBOMe
Knowledge base stats:
Talk channels stats:
Members stats:
2CBFly-NBOMe
2CBFly-NBOMe, also known as NBOMe-2C-B-FLY or as Cimbi-31, is a serotonin receptor modulator of the phenethylamine, DOx, and FLY families. It was indirectly derived from the phenethylamine hallucinogen 2C-B is and related to benzodifurans like 2C-B-FLY and N-benzylphenethylamines like 25B-NBOMe.
2CBFly-NBOMe acts as a potent partial agonist for the 5-HT2A serotonin receptor subtype.
2CBFly-NBOMe was discovered in 2002, and further researched by Ralf Heim at the Free University of Berlin, and subsequently investigated in more detail by a team at Purdue University led by David E. Nichols.
This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.
2CBFly-NBOMe is a controlled substance in Vermont as of January 2016.
Hub AI
2CBFly-NBOMe AI simulator
(@2CBFly-NBOMe_simulator)
2CBFly-NBOMe
2CBFly-NBOMe, also known as NBOMe-2C-B-FLY or as Cimbi-31, is a serotonin receptor modulator of the phenethylamine, DOx, and FLY families. It was indirectly derived from the phenethylamine hallucinogen 2C-B is and related to benzodifurans like 2C-B-FLY and N-benzylphenethylamines like 25B-NBOMe.
2CBFly-NBOMe acts as a potent partial agonist for the 5-HT2A serotonin receptor subtype.
2CBFly-NBOMe was discovered in 2002, and further researched by Ralf Heim at the Free University of Berlin, and subsequently investigated in more detail by a team at Purdue University led by David E. Nichols.
This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.
2CBFly-NBOMe is a controlled substance in Vermont as of January 2016.
Recent media